News & Updates

A recent study has observed a possible link between cataract surgery and a reduced risk of cognitive impairment and dementia, indicating cataract-related vision impairment as a potentially modifiable risk factor for cognitive decline.

The antilipidemic drug fenofibrate averts or delays diabetic retinopathy (DR) in diabetes patients with early retinal changes in the LENS trial, potentially paving the way for the least invasive route of drug delivery in this population.

Nearly half of dementia cases could be prevented or delayed by addressing 14 modifiable risk factors starting from childhood, including two new risk factors – high LDL-cholesterol (LDL-C) level and untreated vision loss – according to a report of the 2024 Lancet Commission on dementia.

A recent study has found no evidence supporting the association of intraocular pressure (IOP) fluctuation, as measured in clinical practice, with visual field (VF) progression in patients with glaucoma.